Suppr超能文献

[突尼斯烧伤患者中碳青霉烯酶的分布]

[DISTRIBUTION OF CARBAPENEMASES IN TUNISIAN BURN PATIENTS].

作者信息

Mokline A, Zarrouk S, Jemi I, Fraj H, Gasri B, Ben Saad M, Thabet L, Messadi A A

出版信息

Ann Burns Fire Disasters. 2024 Jun 30;37(2):106-111. eCollection 2024 Jun.

Abstract

Resistance to carpabenems in burns is rapidly spreading in many countries. Therefore identification of carbapenemase pathogen carriers is imperative in order to establish adequate infection control precautions and stop outbreaks of these multidrug-resistant bacteria. The aim of our study was to evaluate the distribution of carbapenemase producers in burn patients admitted to a burn center in Tunisia over 9 months. PCR for carbapenemase portage was performed in all patients within 48 hours of admission. Seventeen patients carried a single carbapenemase, 11 carried two, and 25 carried three. The enzymes detected were VIM (n=41), NDM (n=41) and OXA48 (n=32). Enzyme mapping revealed two main areas of carriage in central western Tunisia: Kairouan (NDM/OXA48) and Kasserine (NDM/VIM). Predictive factors for carriage of carbapenemase were: prior antibiotic therapy (n=24); mechanical ventilation (n=30); vascular catheterization (n=31) and a previous stay in intensive care (n=11).

摘要

在许多国家,烧伤患者对碳青霉烯类药物的耐药性正在迅速蔓延。因此,识别碳青霉烯酶病原体携带者对于建立适当的感染控制预防措施并阻止这些多重耐药菌的爆发至关重要。我们研究的目的是评估突尼斯一家烧伤中心9个月内入院的烧伤患者中碳青霉烯酶产生菌的分布情况。在所有患者入院48小时内进行碳青霉烯酶携带情况的PCR检测。17例患者携带一种碳青霉烯酶,11例携带两种,25例携带三种。检测到的酶为VIM(n = 41)、NDM(n = 41)和OXA48(n = 32)。酶谱分析显示突尼斯中西部有两个主要携带区域:凯鲁万(NDM/OXA48)和凯塞林(NDM/VIM)。碳青霉烯酶携带的预测因素为:先前的抗生素治疗(n = 24);机械通气(n = 30);血管插管(n = 31)以及先前在重症监护病房住院(n = 11)。

相似文献

1
[DISTRIBUTION OF CARBAPENEMASES IN TUNISIAN BURN PATIENTS].
Ann Burns Fire Disasters. 2024 Jun 30;37(2):106-111. eCollection 2024 Jun.
3
Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in Egypt.
Infect Genet Evol. 2020 Jan;77:104065. doi: 10.1016/j.meegid.2019.104065. Epub 2019 Oct 18.
4
[Not Available].
Ann Burns Fire Disasters. 2019 Mar 31;32(1):10-16.
6
Prevalence and clonal relatedness of NDM and OXA-48-producing in a tertiary care hospital in South India.
J Lab Physicians. 2019 Oct-Dec;11(4):312-316. doi: 10.4103/JLP.JLP_111_19.
8
Carbapenemase Producing Gram-Negative Bacteria in Tunisia: History of Thirteen Years of Challenge.
Infect Drug Resist. 2020 Nov 23;13:4177-4191. doi: 10.2147/IDR.S259562. eCollection 2020.

本文引用的文献

1
Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species.
J Hosp Infect. 2020 Apr;104(4):456-468. doi: 10.1016/j.jhin.2020.01.005. Epub 2020 Jan 10.
2
[Not Available].
Ann Burns Fire Disasters. 2019 Mar 31;32(1):10-16.
3
Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):383-393. doi: 10.1007/s10096-018-3438-9. Epub 2018 Nov 28.
4
Metallo-β-lactamases and class D carbapenemases in south-east Tunisia: Implication of mobile genetic elements in their dissemination.
Int J Antimicrob Agents. 2018 Dec;52(6):871-877. doi: 10.1016/j.ijantimicag.2018.06.002. Epub 2018 Jun 15.
5
Trends in carbapenemase-producing Enterobacteriaceae, France, 2012 to 2014.
Euro Surveill. 2017 Feb 9;22(6). doi: 10.2807/1560-7917.ES.2017.22.6.30461.
7
Early detection of metallo-β-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals.
Int J Antimicrob Agents. 2016 Jul;48(1):46-50. doi: 10.1016/j.ijantimicag.2016.03.007. Epub 2016 Apr 25.
8
Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology.
Med Mal Infect. 2015 Jan-Feb;45(1-2):34-40. doi: 10.1016/j.medmal.2014.12.003. Epub 2015 Jan 29.
9
Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia.
Antimicrob Agents Chemother. 2013 Aug;57(8):4089-90. doi: 10.1128/AAC.00536-13. Epub 2013 Jun 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验